These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17691212)

  • 61. Development and validation of analytical procedure--control of residual 2-iodopropane in latanoprost.
    Groman A; Stolarczyk EU
    Acta Pol Pharm; 2010; 67(6):673-6. PubMed ID: 21229885
    [No Abstract]   [Full Text] [Related]  

  • 62. Analytical control of process impurities in Pazopanib hydrochloride by impurity fate mapping.
    Li Y; Liu DQ; Yang S; Sudini R; McGuire MA; Bhanushali DS; Kord AS
    J Pharm Biomed Anal; 2010 Aug; 52(4):493-507. PubMed ID: 20189340
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Imipramine: a model drug for P450 research.
    Brøsen K; Skjelbo E; Nielsen KK
    Methods Enzymol; 1996; 272():177-86. PubMed ID: 8791776
    [No Abstract]   [Full Text] [Related]  

  • 64. Improvement of chemical analysis of antibiotics. VII. Comparison of analytical methods for determination of impurities in tetracycline pharmaceutical preparations.
    Oka H; Suzuki M
    J Chromatogr; 1984 Nov; 314():303-11. PubMed ID: 6526884
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Determination of some tricyclic neuroleptics by reversed-phase high-performance liquid chromatography with ultraviolet and polarographic detection.
    Pacáková V; Stulík K; Tomková H
    J Chromatogr; 1984 Aug; 298(2):309-18. PubMed ID: 6480754
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Examination of microbiological quality of pharmaceutical raw materials.
    Bomblies L; Weiss C; Beckmann G
    Pharmeur Sci Notes; 2007 Sep; 2007(1):1-7. PubMed ID: 17993088
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inter-laboratory reproducibility of the LC-ELSD method for the control of composition of sesame oil recently introduced in the Ph. Eur.
    Lodi A; Mercier I; Prilleux B; Streissel P; Thietard L
    Pharmeur Sci Notes; 2007 Sep; 2007(1):39-41. PubMed ID: 17993093
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An overview of the recent trends in development of HPLC methods for determination of impurities in drugs.
    Nageswara Rao R; Nagaraju V
    J Pharm Biomed Anal; 2003 Oct; 33(3):335-77. PubMed ID: 14550856
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The central role of chemistry in 'quality by design' approaches to drug development.
    Grewal NK; Leadbeater NE
    Future Med Chem; 2012 Sep; 4(14):1799-810. PubMed ID: 23043477
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Optimisation and validation of a fast HPLC method for the quantification of sulindac and its related impurities.
    Krier F; Brion M; Debrus B; Lebrun P; Driesen A; Ziemons E; Evrard B; Hubert P
    J Pharm Biomed Anal; 2011 Mar; 54(4):694-700. PubMed ID: 21131156
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of a reversed-phase ion-pairing liquid chromatographic assay of daunorubicin for pharmacopoeial use.
    Miller JH; Pascal C; Tissieres M
    J Chromatogr; 1987 Apr; 392():361-70. PubMed ID: 3474237
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analytical approaches for the detection of epoxides and hydroperoxides in active pharmaceutical ingredients, drug products and herbals.
    Elder DP; Snodin D; Teasdale A
    J Pharm Biomed Anal; 2010 Apr; 51(5):1015-23. PubMed ID: 20031361
    [TBL] [Abstract][Full Text] [Related]  

  • 73. GLC method for iminodibenzyl and desipramine impurities in imipramine hydrochloride and its formulated products.
    Thompson DW
    J Pharm Sci; 1982 May; 71(5):536-8. PubMed ID: 7097500
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Total organic carbon (VCSN and VWP) and HPLC analysis for cleaning validation in a pharmaceutical pilot plant.
    Queralt M; García-Montoya E; Pérez-Lozano P; Suñé-Negre JM; Miñarro M; Ticó JR
    PDA J Pharm Sci Technol; 2009; 63(1):42-57. PubMed ID: 19455941
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Chromatographic determination of ointment bases and emulsifying agents in European and German pharmacopoeias].
    Kovar KA; Langlouis H; Auterhoff H
    Pharm Weekbl Sci; 1983 Aug; 5(4):134-41. PubMed ID: 6622206
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Technical Report No. 38. Manufacturing chromatography systems postapproval changes (ChromPAC): chemistry, manufacturing, and controls documentation.
    PDA Manufacturing Chromatography Systems PAC Taskforce
    PDA J Pharm Sci Technol; 2006 Mar; 60(1 Suppl TR38):1-29. PubMed ID: 16696189
    [No Abstract]   [Full Text] [Related]  

  • 77. Column selection for pharmaceutical analyses based on a column classification using four test parameters.
    Kóczián K; Haghedooren E; Dragovic S; Noszál B; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2007 Aug; 44(4):894-905. PubMed ID: 17531419
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A SepPak HPLC method for tricyclic antidepressant drugs in human vitreous humor.
    Evenson MA; Engstrand DA
    J Anal Toxicol; 1989; 13(6):322-5. PubMed ID: 2558256
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Standards and specifications for drugs.
    Johnson CA
    Br Med Bull; 1970 Sep; 26(3):227-32. PubMed ID: 4922457
    [No Abstract]   [Full Text] [Related]  

  • 80. Development of quality-by-design analytical methods.
    Vogt FG; Kord AS
    J Pharm Sci; 2011 Mar; 100(3):797-812. PubMed ID: 21280050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.